On the Absolute Stereochemistry of Tolterodine: A Circular Dichroism Study

被引:11
作者
Gorecki, Marcin [1 ,2 ]
Zullo, Valerio [1 ]
Iuliano, Anna [1 ]
Pescitelli, Gennaro [1 ]
机构
[1] Univ Pisa, Dipartimento Chim & Chim Ind, Via Moruzzi 13, I-56124 Pisa, Italy
[2] Polish Acad Sci, Inst Organ Chem, Kasprzaka 44-52 St, PL-01224 Warsaw, Poland
关键词
absolute configuration; drug enantiomers; circular dichroism calculations; conformational analysis; variable-temperature CD; solvent dependent CD; ENANTIOSELECTIVE SYNTHESIS; CHIROPTICAL PROPERTIES; ASYMMETRIC-SYNTHESIS; BENZENE CHROMOPHORE; OVERACTIVE BLADDER; TDDFT CALCULATIONS; ARYLBORONIC ACIDS; SPECTRA; CONFIGURATIONS; 1,4-ADDITION;
D O I
10.3390/ph12010021
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tolterodine (1) is a potent muscarinic receptor antagonist used in the treatment of overactive urinary bladder (OAB) syndrome. Tolterodine is chiral and it was patented, and is currently marketed, as the l-tartrate salt of the (R)-enantiomer. However, the existing literature does not offer an ultimate proof of a stereoselective mode of action of 1. A second open stereochemical issue concerns the absolute configuration (AC) of 1. Neither the original patents nor subsequent studies have established the AC of 1 in an unambiguous way, although the AC of the l-tartrate salt of 1 was assigned by X-ray diffractometry. Finally, neither electronic nor vibrational circular dichroism (ECD and VCD) spectra of 1 are reported so far. We performed a thorough ECD/VCD study of 1 in different solvents and at variable temperatures. Solvent and temperature dependence highlighted the existence of moderate flexibility which was confirmed by molecular modelling. ECD calculations with time-dependent density functional theory (TDDFT) accurately reproduced the experimental spectra and allowed us to confirm the AC of 1 in an independent way.
引用
收藏
页数:12
相关论文
共 57 条
[1]  
Alberg G. S, 1996, U. S. Patent, Patent No. [6310103B1, 6310103]
[2]  
Ananchenko Gennady, 2017, Profiles Drug Subst Excip Relat Methodol, V42, P339, DOI 10.1016/bs.podrm.2017.02.007
[3]  
[Anonymous], 1991, Electronic Spectra and Electronic Structure of Polyatomic Molecules
[4]   Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis [J].
Appell, RA .
UROLOGY, 1997, 50 (6A) :90-96
[5]   Application of electronic circular dichroism in configurational and conformational analysis of organic compounds [J].
Berova, Nina ;
Di Bari, Lorenzo ;
Pescitelli, Gennaro .
CHEMICAL SOCIETY REVIEWS, 2007, 36 (06) :914-931
[6]  
Bruhn T., 2017, SpecDis
[7]   SpecDis: Quantifying the Comparison of Calculated and Experimental Electronic Circular Dichroism Spectra [J].
Bruhn, Torsten ;
Schaumloeffel, Anu ;
Hemberger, Yasmin ;
Bringmann, Gerhard .
CHIRALITY, 2013, 25 (04) :243-249
[8]   Solvation of a chiral carboxylic acid: effects of hydrogen bonding on the IR and VCD spectra of α-methoxyphenylacetic acid [J].
Bunnemann, Karoline ;
Merten, Christian .
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2017, 19 (29) :18948-18956
[9]   Computational study of conformational and chiroptical properties of (2R,3S,4R)-(+)-3,3′,4,4′,7-flavanpentol [J].
Cappelli, C ;
Bronco, S ;
Monti, S .
CHIRALITY, 2005, 17 (09) :577-589
[10]   Rhodium-catalyzed asymmetric 1,4-addition of arylboronic acids to coumarins: Asymmetric synthesis of (R)-tolterodine [J].
Chen, G ;
Tokunaga, N ;
Hayashi, T .
ORGANIC LETTERS, 2005, 7 (11) :2285-2288